Close Menu

NEW YORK – Scorpion Therapeutics launched on Monday after raising $108 million in Series A funding.

The financing round was led by Atlas Venture, Omega Funds, and Vida Ventures, and included Abingworth and Partners HealthCare Innovation.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.